Levi v. United States

140 F. 126, 1905 U.S. App. LEXIS 4772
U.S. Circuit Court for the District of Southern New York·Decided May 17, 1905·No. No. 3,605·Published

Opinion

TOWNSEND, Circuit Judge

(orally). The merchandise in question, known as “chrysarobin,” was assessed for duty by the Collector of Customs as a medicinal preparation, under Tariff Act July 24, 1897, c. 11, § 1, Schedule A, par. 68, 30 Stat. 154 [U. S. Comp. St. 1901, p. 1631], and is claimed by the importer as properly dutiable under paragraph 20 (30 Stat. 152 [U. S. Comp. St. 1901, p. 1628]) of the same act as a “drug advanced in value,” etc. This case is controlled by the decision of the Circuit Court of Appeals 'for this circuit in United States v. Merck (T. D. 20,046) 136 Fed. 817.

The decision of the Board of General Appraisers is reversed.

Free access — add to your briefcase to read the full text and ask questions with AI

Levi v. United States, 140 F. 126, 1905 U.S. App. LEXIS 4772 (circtsdny 1905).

140 F. 126 (Levi v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Merck & Co.
136 F. 817 (Second Circuit, 1905)